NEW YORK, NY--(Marketwire - November 19, 2008) - Tongli Pharmaceuticals (OTCBB: TGLP), a pharmaceutical company specializing in development, manufacture, and commercialization of a wide range of prescription and over the counter (“OTC”) pharmaceutical products, today announced financial results for the quarter ended September 30, 2008.
